Uneek Mehra - Sep 15, 2021 Form 4 Insider Report for Myovant Sciences Ltd. (MYOV)

Role
Principal Financial Officer
Signature
/s/ Matthew Lang, Attorney-in-fact
Stock symbol
MYOV
Transactions as of
Sep 15, 2021
Transactions value $
$0
Form type
4
Date filed
9/17/2021, 04:31 PM
Previous filing
Sep 9, 2021
Next filing
Apr 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYOV Common Shares Award $0 +103K $0.00 103K Sep 15, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MYOV Stock Options (Right to Buy) Award $0 +165K $0.00 165K Sep 15, 2021 Common Shares 165K $21.83 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Common Shares are to be acquired upon the vesting of certain Restricted Stock Units ("RSUs") granted to the Reporting Person. 1/4 of the Common Shares underlying the RSUs vest on September 15, 2022, and 1/16 of the Common Shares underlying the RSUs vest each quarter thereafter, provided the Reporting Person has provided continuous service to the Issuer or its affiliates on each such date.
F2 1/4 of the Common Shares underlying this option vest on September 15, 2022, and 1/16 of the Common Shares underlying this option vest each quarter thereafter, provided the Reporting Person has provided continuous service to the Issuer or its affiliates on each such date.